Outset Medical, Inc.

For the period ended Dec 31, 2025. Filed Feb 13, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 13, 2026

OM$4.22+2.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Statements of Convertible Preferred Stock and Stockholders’ Equity

Convertible Preferred Stock · Common Stock · AdditionalPaid-in · AccumulatedOtherComprehensive · Accumulated · TotalStockholders'
	Shares	Amount	Shares	Amount	Capital	Income (Loss)	Deficit	Equity
Balance as of December 31, 2022	—	$—	3,231	$3	$1,035,501	$(564)	$(788,950)	$245,990
Issuance of common stock through employee stock purchase plan	—	—	37	—	7,510	—	—	7,510
Issuance of common stock for settlement of RSUs	—	—	47	—	—	—	—	—
Stock option exercises	—	—	39	—	2,917	—	—	2,917
Stock-based compensation expense	—	—	—	—	38,634	—	—	38,634
Unrealized gain on available-for-sale securities	—	—	—	—	—	632	—	632
Net loss	—	—	—	—	—	—	(172,797)	(172,797)
Balance as of December 31, 2023	—	$—	3,354	$3	$1,084,562	$68	$(961,747)	$122,886
Issuance of common stock through employee stock purchase plan	—	—	70	1	2,200	—	—	2,201
Issuance of common stock for settlement of RSUs	—	—	101	—	295	—	—	295
Stock option exercises	—	—	5	—	83	—	—	83
Stock-based compensation expense	—	—	—	—	29,356	—	—	29,356
Unrealized loss on available-for-sale securities	—	—	—	—	—	(26)	—	(26)
Net loss	—	—	—	—	—	—	(127,976)	(127,976)
Balance as of December 31, 2024	—	$—	3,530	$4	$1,116,496	$42	$(1,089,723)	$26,819
Issuance of Series A convertible preferred stock, net of issuance costs	863	161,071	—	—	—	—	—	—
Conversion of convertible preferred stock to common stock	(863)	(161,071)	14,389	14	161,057	—	—	161,071
Issuance of common stock warrant, net of issuance costs	—	—	—	—	4,330	—	—	4,330
Issuance of common stock through employee stock purchase plan	—	—	87	—	639	—	—	639
Issuance of common stock for settlement of RSUs	—	—	163	—	—	—	—	—
Stock option exercises	—	—	—	—	—	—	—	—
Stock-based compensation expense	—	—	—	—	15,616	—	—	15,616
Unrealized gain on available-for-sale securities	—	—	—	—	—	130	—	130
Net loss	—	—	—	—	—	—	(81,653)	(81,653)
Balance as of December 31, 2025	—	$—	18,169	$18	$1,298,138	$172	$(1,171,376)	$126,952

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.